Exponent (EXPO) Stock Price, News & Analysis

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EXPO shares.
View EXPO analyst ratings or view top-rated stocks.

2 equities research analysts have issued twelve-month price objectives for Exponent's stock. Their EXPO share price targets range from $95.00 to $99.00. On average, they anticipate the company's share price to reach $97.00 in the next year. This suggests a possible upside of 24.2% from the stock's current price.
View analysts price targets for EXPO or view top-rated stocks among Wall Street analysts.

Exponent's stock was trading at $88.04 at the start of the year. Since then, EXPO shares have decreased by 11.3% and is now trading at $78.12.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our EXPO earnings forecast.

Exponent will be holding an earnings conference call on Thursday, April 25th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9671556#".

Exponent, Inc. (NASDAQ:EXPO) released its earnings results on Thursday, February, 1st. The business services provider reported $0.41 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.44 by $0.03. The business services provider had revenue of $113.87 million for the quarter, compared to analysts' expectations of $119.11 million. Exponent had a trailing twelve-month return on equity of 28.49% and a net margin of 18.69%. The company's revenue was up 1.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 EPS.

Exponent announced a quarterly dividend on Thursday, February 1st. Investors of record on Friday, March 8th will be given a dividend of $0.28 per share on Friday, March 22nd. This represents a $1.12 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Thursday, March 7th. This is an increase from the stock's previous quarterly dividend of $0.26.
Read our dividend analysis for EXPO.

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.43%. The company has been increasing its dividend for 6 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 57.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 57.14% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

ETFs with the largest weight of Exponent (NASDAQ:EXPO) stock in their portfolio include iShares Emergent Food and AgTech Multisector ETF (IVEG), ProShares Russell 2000 Dividend Growers ETF (SMDV), Argent Mid Cap ETF (AMID) and Hypatia Women CEO ETF (WCEO).Franklin U.S. Small Cap Multifactor Index ETF (FLQS).

Exponent's stock split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were distributed to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Exponent's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Bridge City Capital LLC (0.07%), CWM LLC (0.02%), Park Avenue Securities LLC (0.01%), LVW Advisors LLC (0.01%), Mather Group LLC. (0.00%) and Janiczek Wealth Management LLC (0.00%). Insiders that own company stock include Bradley A James, Carol Lindstrom, Eric Guyer, George H Brown, Harri Kytomaa, Joseph Rakow, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends.

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.